Cargando…

Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica

OBJECTIVE: Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Fumitaka, Nishihara, Hideaki, Sano, Yasuteru, Takeshita, Yukio, Takahashi, Shiori, Maeda, Toshihiko, Takahashi, Toshiyuki, Abe, Masaaki, Koga, Michiaki, Kanda, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374747/
https://www.ncbi.nlm.nih.gov/pubmed/25811465
http://dx.doi.org/10.1371/journal.pone.0122000
_version_ 1782363537273782272
author Shimizu, Fumitaka
Nishihara, Hideaki
Sano, Yasuteru
Takeshita, Yukio
Takahashi, Shiori
Maeda, Toshihiko
Takahashi, Toshiyuki
Abe, Masaaki
Koga, Michiaki
Kanda, Takashi
author_facet Shimizu, Fumitaka
Nishihara, Hideaki
Sano, Yasuteru
Takeshita, Yukio
Takahashi, Shiori
Maeda, Toshihiko
Takahashi, Toshiyuki
Abe, Masaaki
Koga, Michiaki
Kanda, Takashi
author_sort Shimizu, Fumitaka
collection PubMed
description OBJECTIVE: Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera. METHODS: We measured the levels of 27 cytokines/chemokines in human brain microvascular endothelial cells (BMECs) after exposure to sera obtained from patients with the acute and stable phases of anti-AQP4 antibody-positive NMO spectrum disorder (NMOSD), multiple sclerosis (MS) patients and healthy controls (HC) using a multiplexed fluorescent bead-based immunoassay system. RESULTS: The induced protein (IP)-10 level in the cells was markedly increased following exposure to acute phase NMOSD sera. Other cytokines/chemokines including interleukin (IL)-6 and monocyte chemotactic protein (MCP)-1 were also significantly increased in the acute NMOSD group compared to both the MS and HC groups. The up-regulation of the IP-10 levels in the cells after exposure to the acute-phase NMOSD sera was also observed using another specified ELISA, and this effect was significantly decreased during the remission phase in the individual NMOSD patients. Furthermore, the increase in the level of IP-10 after exposure to the sera was significantly correlated with the cerebrospinal fluid/serum albumin ratio. CONCLUSIONS: Sera from the acute phase of NMO markedly increased the autocrine secretion of IP-10 by BMECs. The over-production of IP-10 in BMECs may play an important role in the pathogenesis of NMO and may therefore help to mediate the trafficking of T cells expressing its receptor across the BBB.
format Online
Article
Text
id pubmed-4374747
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43747472015-04-04 Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica Shimizu, Fumitaka Nishihara, Hideaki Sano, Yasuteru Takeshita, Yukio Takahashi, Shiori Maeda, Toshihiko Takahashi, Toshiyuki Abe, Masaaki Koga, Michiaki Kanda, Takashi PLoS One Research Article OBJECTIVE: Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera. METHODS: We measured the levels of 27 cytokines/chemokines in human brain microvascular endothelial cells (BMECs) after exposure to sera obtained from patients with the acute and stable phases of anti-AQP4 antibody-positive NMO spectrum disorder (NMOSD), multiple sclerosis (MS) patients and healthy controls (HC) using a multiplexed fluorescent bead-based immunoassay system. RESULTS: The induced protein (IP)-10 level in the cells was markedly increased following exposure to acute phase NMOSD sera. Other cytokines/chemokines including interleukin (IL)-6 and monocyte chemotactic protein (MCP)-1 were also significantly increased in the acute NMOSD group compared to both the MS and HC groups. The up-regulation of the IP-10 levels in the cells after exposure to the acute-phase NMOSD sera was also observed using another specified ELISA, and this effect was significantly decreased during the remission phase in the individual NMOSD patients. Furthermore, the increase in the level of IP-10 after exposure to the sera was significantly correlated with the cerebrospinal fluid/serum albumin ratio. CONCLUSIONS: Sera from the acute phase of NMO markedly increased the autocrine secretion of IP-10 by BMECs. The over-production of IP-10 in BMECs may play an important role in the pathogenesis of NMO and may therefore help to mediate the trafficking of T cells expressing its receptor across the BBB. Public Library of Science 2015-03-26 /pmc/articles/PMC4374747/ /pubmed/25811465 http://dx.doi.org/10.1371/journal.pone.0122000 Text en © 2015 Shimizu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Shimizu, Fumitaka
Nishihara, Hideaki
Sano, Yasuteru
Takeshita, Yukio
Takahashi, Shiori
Maeda, Toshihiko
Takahashi, Toshiyuki
Abe, Masaaki
Koga, Michiaki
Kanda, Takashi
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
title Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
title_full Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
title_fullStr Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
title_full_unstemmed Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
title_short Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
title_sort markedly increased ip-10 production by blood-brain barrier in neuromyelitis optica
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374747/
https://www.ncbi.nlm.nih.gov/pubmed/25811465
http://dx.doi.org/10.1371/journal.pone.0122000
work_keys_str_mv AT shimizufumitaka markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT nishiharahideaki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT sanoyasuteru markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT takeshitayukio markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT takahashishiori markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT maedatoshihiko markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT takahashitoshiyuki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT abemasaaki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT kogamichiaki markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica
AT kandatakashi markedlyincreasedip10productionbybloodbrainbarrierinneuromyelitisoptica